Your browser doesn't support javascript.
loading
Optimising the use of medicines to reduce acute kidney injury in children and babies.
Oni, L; Hawcutt, D B; Turner, M A; Beresford, M W; McWilliam, S; Barton, C; Park, B K; Murray, P; Wilm, B; Copple, I; Floyd, R; Peak, M; Sharma, A; Antoine, D J.
Afiliação
  • Oni L; Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Paediatric Nephrology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK. Electronic address: louise.oni@liverpool.ac.uk.
  • Hawcutt DB; Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Paediatric Pharmacology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK.
  • Turner MA; Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Centre for Better Births, Liverpool Women's Hospital, Liverpool, UK.
  • Beresford MW; Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK.
  • McWilliam S; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Barton C; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Paediatric Oncology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK.
  • Park BK; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Murray P; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Wilm B; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Copple I; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Floyd R; Department of Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Peak M; Department of Research and Development, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK.
  • Sharma A; Department of Nephrology, The Royal Liverpool and Broadgreen University Hospitals NHS Foundation Trust, Liverpool, UK.
  • Antoine DJ; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Pharmacol Ther ; 174: 55-62, 2017 Jun.
Article em En | MEDLINE | ID: mdl-28202365

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Injúria Renal Aguda Tipo de estudo: Screening_studies Limite: Adolescent / Child / Humans / Infant Idioma: En Revista: Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Injúria Renal Aguda Tipo de estudo: Screening_studies Limite: Adolescent / Child / Humans / Infant Idioma: En Revista: Pharmacol Ther Ano de publicação: 2017 Tipo de documento: Article